Investors

Illuminare Biotechnologies is a privately held Delaware C-Corporation. Accredited investors interested in learning more about Illuminare should contact Illuminare CEO, Walter Greenblatt Illuminare-1 has been developed to date with substantial equity financing from Memorial Sloan Kettering, General Electric, family offices and angel investors.